Search

Your search keyword '"Zhu Dalong"' showing total 561 results

Search Constraints

Start Over You searched for: Author "Zhu Dalong" Remove constraint Author: "Zhu Dalong" Language english Remove constraint Language: english
561 results on '"Zhu Dalong"'

Search Results

1. Advanced glycation end product levels were correlated with inflammation and carotid atherosclerosis in type 2 diabetes patients

7. Consensus of Chinese experts on strengthening personalized prevention and treatment of type 2 diabetes

10. Clinical expert consensus on the assessment and protection of pancreatic islet β-cell function in type 2 diabetes mellitus

12. Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial

13. Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial

15. Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis

21. Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS)

25. Clinical investigation of glucokinase activators for the restoration of glucose homeostasis in diabetes.

26. Effect of baseline characteristics on the efficacy of dulaglutide added to basal insulin in Chinese patients with type 2 diabetes: A subgroup analysis of AWARD‐CHN3.

33. Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study

38. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial

40. Blood pressure targets for prevention of cognitive decline in patients with diabetes and hypertension: Design of the Blood Pressure Control Target in Diabetes (BPROAD) Cognitive Study.

41. Rationale and design for the Blood Pressure Control Target in Diabetes (BPROAD) study.

42. Efficacy and safety of adding once‐weekly dulaglutide to basal insulin for inadequately controlled type 2 diabetes in Chinese patients (AWARD‐CHN3): A randomized, double‐blind, placebo‐controlled, phase III trial.

43. Prevalence and risk factors of diabetic peripheral neuropathy: A population‐based cross‐sectional study in China.

48. Weight loss and metabolic benefits of bariatric surgery in China: A multicenter study.

Catalog

Books, media, physical & digital resources